Earnings History Data for Evoke Pharma, Inc. (EVOK) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Evoke Pharma, Inc.
Evoke Pharma, Inc. is a specialty pharmaceutical company focused primarily on the development of drugs to treat gastrointestinal disorders and diseases. The Company's lead product candidate, EVK-001, is in late stage clinical testing which is intended for the treatment of diabetic gastroparesis. Evoke Pharma, Inc. is based in San Diego, California.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 13-08-2024 | PM | EVOK | Evoke Pharma, Inc. | 4.18 | -0.93 | 0.00 | -6.72 | Evoke Pharma GAAP EPS of -$0.93, revenue of $2.55M [8/13/2024 9:05 AM] |
5.65 | -0.09 (-1.57%) |
0.0 | 0.0 (0.00%) |
4.32 - 18.60 | 3,449 | 10,000 | 0 | ||
|
|
||||||||||||||||||
| 14-03-2024 | AH | EVOK | Evoke Pharma, Inc. | 2.17 | -0.59 | 0.00 | -0.53 | Evoke Pharma GAAP EPS of -$0.59 revenue of $1.7M [3/14/2024 4:42 PM] |
0.64 | -0.03 (-5.13%) |
0.61 | -0.06 (-9.58%) |
0.56 - 3.50 | 79,905 | 60,000 | 30,370 | ||
| 09-11-2023 | PM | EVOK | Evoke Pharma, Inc. | 3.84 | -0.51 | 0.00 | -0.60 | Evoke Pharma GAAP EPS of -$0.51, revenue of $1.56M [11/9/2023 9:00 AM] |
1.28 | 0.12 (10.34%) |
0.0 | 0.0 (0.00%) |
0.92 - 5.96 | 26,610 | 0 | 0 | ||
| 10-08-2023 | PM | EVOK | Evoke Pharma, Inc. | 4.71 | -0.56 | 0.00 | -0.71 | Evoke Pharma GAAP EPS of -$0.56 beats by $0.17, revenue of $1.13M beats by $0.03M [8/10/2023 10:24 AM] |
1.37 | -0.04 (-2.84%) |
1.50 | 0.12 (8.70%) |
1.35 - 5.96 | 14,199 | 20,000 | 265 | ||
| 15-05-2023 | AH | 4:05 PM ET (May 15) |
EVOK | Evoke Pharma, Inc. | 6.65 | -0.67 | 0.00 | -0.84 | Evoke Pharma GAAP EPS of -$0.67 misses by $0.09, revenue of $0.81M misses by $0.19M [5/15/2023 5:01 PM] |
1.82 | -0.11 (-5.50%) |
0.0 | 0.0 (0.00%) |
1.37 - 5.96 | 11,538 | 10,000 | 0 | |
| 21-03-2023 | AH | 4:05 PM ET (Mar 21) |
EVOK | Evoke Pharma, Inc. | 11.00 | -0.53 | 0.00 | -0.60 | Evoke Pharma GAAP EPS of $0.54 beats by $1.07, revenue of $0.79M misses by $0.1M [3/21/2023 4:24 PM] |
2.64 | -0.46 (-14.91%) |
3.15 | 0.05 (1.61%) |
1.37 - 16.80 | 35,125 | 20,000 | 729 | |
| 09-11-2022 | AH | 4:05 PM ET (Nov 9) |
EVOK | Evoke Pharma, Inc. | 5.62 | -0.60 | 0.00 | -0.72 | Evoke Pharma GAAP EPS of -$0.60 beats by $0.06, revenue of $0.83M beats by $0.26M [11/9/2022 4:31 PM] |
1.82 | 0.21 (13.24%) |
1.88 | 0.27 (16.77%) |
1.55 - 16.80 | 36,344 | 10,000 | 2,112 | |
| 10-08-2022 | AH | 4:05 PM ET (Aug 10) |
EVOK | Evoke Pharma, Inc. | 10.16 | -0.71 | 0.00 | -0.84 | 2.82 | -0.29 (-9.38%) |
3.13 | 0.02 (0.64%) |
2.03 - 18.96 | 104,391 | 90,000 | 419 | ||
| 10-05-2022 | AH | 4:05 PM ET (May 10) |
EVOK | Evoke Pharma, Inc. | 14.30 | -0.07 | 0.00 | -0.08 | Evoke Pharma GAAP EPS of -$0.07 misses by $0.03, revenue of $0.42M misses by $0.12M [5/10/2022 4:37 PM] |
0.2725 | -0.07 (-21.01%) |
0.31 | -0.03 (-9.83%) |
0.26 - 1.60 | 2,095,834 | 5,790,000 | 137,194 | |
| 08-03-2022 | AH | 4:05 PM ET (Mar 8) |
EVOK | Evoke Pharma, Inc. | 19.57 | -0.05 | 0.00 | -0.09 | Evoke Pharma GAAP EPS of $0.05 beats by $0.13, revenue of $0.36M misses by $0.15M [3/8/2022 4:34 PM] |
0.5170 | -0.09 (-14.18%) |
0.56 | -0.04 (-7.04%) |
0.47 - 3.20 | 272,254 | 60,000 | 5,878 | |
| 10-11-2021 | AH | 4:05 PM ET (Nov 10) |
EVOK | Evoke Pharma, Inc. | 42.82 | -0.06 | 0.00 | -0.08 | Evoke Pharma EPS beats by $0.01, beats on revenue [11/10/2021 4:49 PM] |
1.04 | -0.17 (-14.05%) |
1.22 | 0.01 (0.83%) |
0.96 - 4.80 | 660,530 | 130,000 | 11,919 | |
| 12-08-2021 | AH | 4:05 PM ET (Aug 12) |
EVOK | Evoke Pharma, Inc. | 36.90 | -0.07 | -0.04 | -0.28 | Evoke Pharma EPS beats by $0.01, beats on revenue [8/12/2021 4:25 PM] |
1.34 | 0.22 (19.20%) |
1.19 | 0.07 (6.25%) |
1.04 - 5.87 | 18,036,802 | 80,000 | 21,721 | |
| 12-05-2021 | AH | 4:05 PM ET (May 12) |
EVOK | Evoke Pharma, Inc. | 51.47 | -0.08 | -0.06 | -0.07 | Evoke Pharma EPS misses by $0.01, misses on revenue [5/12/2021 4:26 PM] |
1.14 | -0.38 (-25.25%) |
1.23 | -0.29 (-19.08%) |
1.13 - 6.06 | 1,639,150 | 260,000 | 107,654 | |
| 11-03-2021 | AH | 4:05 PM ET (Mar 11) |
EVOK | Evoke Pharma, Inc. | 87.26 | -0.09 | -0.04 | -0.06 | Evoke Pharma EPS beats by $0.05 [3/11/2021 6:01 PM] |
2.44 | -0.66 (-21.13%) |
2.20 | -0.90 (-29.03%) |
0.79 - 6.06 | 3,156,603 | 426,338 | 451,033 | |
|
||||||||||||||||||
| 12-05-2020 | PM | EVOK | Evoke Pharma, Inc. | 34.24 | -0.07 | -0.05 | -0.11 | Evoke Pharma EPS misses by $0.02 [5/12/2020 8:34 AM] |
1.41 | -0.02 (-1.40%) |
1.37 | -0.06 (-4.20%) |
0.50 - 1.79 | 135,863 | 268,327 | 3,920 | ||
|
|
||||||||||||||||||